 |
 |
 |
 |
 |
 |
IB has been able to facilitate all stages of product discovery, development, and commercialization from invention conception, through reduction to practice, enablement of the invention, and development of a successful regulatory strategy that results in the successful commercialization of the product.
IB has worked with a range of clients from academic researchers interested in their first commercialization to multinational corporations interested in improving their product pipeline. Subject areas have ranged from value-added characteristics of commodity crops to medical therapeutics and diagnostics.
IP Assessment
IB has provided technology assessments for potential acquisitions, joint ventures, etc.:
| + | Identification and vetting of potential gene sources to create value-added transenic commodity crops |
| + | Vetting facility purchases to set up cGMP facilities for biologics |
| + | Review of clinical trail strategy for prognostic of HIV/AIDS therapy success |
IP Evaluation
IB has evaluated the patentability of proposed inventions for basic scientists and clinicians working at universities and hospitals. Some examples include:
| + | Antisense therapeutics to treat diseases of all types |
| + | Gene therapy agents for treatment of neurological diseases and cancer |
IP Strategy
IB has provided strategic advice to start-up companies on regulatory strategies for developing inventions from the laboratory to the market:
| + | A drug for decreasing side-effects associated with alkylating agent chemotherapeutics |
| + | Immunotherapies for certain cancers Ultra-sensitive diagnostics for blood-borne diseases |
